王文芳, 韩燕媚, 谭三阳, 邱小翠. 微小RNA-491在宫颈癌细胞的增殖、侵袭及迁移中的作用及分子机制[J]. 实用临床医药杂志, 2022, 26(9): 8-15. DOI: 10.7619/jcmp.20214920
引用本文: 王文芳, 韩燕媚, 谭三阳, 邱小翠. 微小RNA-491在宫颈癌细胞的增殖、侵袭及迁移中的作用及分子机制[J]. 实用临床医药杂志, 2022, 26(9): 8-15. DOI: 10.7619/jcmp.20214920
WANG Wenfang, HAN Yanmei, TAN Sanyang, QIU Xiaocui. Roles and molecular mechanism of microRNA-491 on proliferation, invasion and migration of cervical cancer cells[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 8-15. DOI: 10.7619/jcmp.20214920
Citation: WANG Wenfang, HAN Yanmei, TAN Sanyang, QIU Xiaocui. Roles and molecular mechanism of microRNA-491 on proliferation, invasion and migration of cervical cancer cells[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 8-15. DOI: 10.7619/jcmp.20214920

微小RNA-491在宫颈癌细胞的增殖、侵袭及迁移中的作用及分子机制

Roles and molecular mechanism of microRNA-491 on proliferation, invasion and migration of cervical cancer cells

  • 摘要:
      目的  探讨微小RNA-491(miR-491)在宫颈癌(CC)细胞增殖、侵袭及迁移中的作用及分子机制。
      方法  收集CC患者的58对癌组织及癌旁组织标本;采用实时荧光定量反转录聚合酶链反应(qRT-PCR)检测CC组织和癌旁组织(对照组)中miR-491和爪蟾驱动蛋白样蛋白2的靶向蛋白(TPX2)的表达水平。将CC细胞系中的Hela和HT-3细胞随机分为NC组磷酸盐缓冲液(PBS)处理、miR-491组(过表达miR-491处理)、si-TPX2组(抑制TPX2)、TPX2组(过表达TPX2)及miR-491+TPX2组(同时过表达miR-491和TPX2)。采用细胞活力和克隆形成实验测定miR-491对CC细胞增殖能力的影响;采用双荧光素酶报告实验验证miR-491和 TPX2 的靶向关系;采用划痕和侵袭实验检测miR-491对CC细胞侵袭和迁移能力的影响;构建裸鼠成瘤模型验证miR-491和TPX2对肿瘤生长的影响。
      结果  miR-491在CC组织和细胞中的表达降低,而TPX2的表达升高,差异有统计学意义(P<0.05)。过表达miR-491能够抑制CC细胞的细胞增殖。双荧光素酶报告结果表明,与NC组比较, miR-491模拟物可以降低PmirGLO-TPX2-3′UTR WT的荧光素酶活性,差异有统计学意义(P<0.05)。细胞活力和凋亡检测结果发现, miR-491能够通过调控TPX2抑制细胞增殖来增高细胞凋亡率。进一步的划痕和transwell检测结果发现, miR-491过表达能够抑制细胞的迁移和侵袭,而TPX2过表达能够促进细胞迁移和侵袭。肿瘤体积和质量检测结果发现, miR-491能够抑制肿瘤生长,而TPX2过表达能够促进肿瘤生长且这种促进作用能够被miR-491逆转。苏木精-伊红染色(HE)检测发现, miR-491组的肿瘤组织出现部分坏死,而TPX2组肿瘤细胞增殖明显。
      结论  miR-491能够通过调控TPX2的表达影响CC进程,为未来CC生物标志物的选择及治疗靶点提供理论依据。

     

    Abstract:
      Objective  To investigate the roles and molecular mechanism of microRNA-491 (miR-491) in the proliferation, invasion and migration of cervical cancer (CC) cells and its molecular mechanism.
      Methods  A total of 58 pairs of cancer tissue and paracancerous tissue samples from CC patients were collected. The expression levels of miR-491 and Xenopus kinesin-like protein 2 target protein (TPX2) in CC tissues and paracancerous tissues were detected by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Hela and HT-3 cells of CC cell line were randomly divided into NC groupphosphate buffer (PBS) treatment, miR-491 group (overexpression of miR-491 treatment), si-TPX2 group (inhibition of TPX2), TPX2 group (overexpression of TPX2) and miR-491+TPX2 group (simultaneous overexpression of miR-491 and TPX2). Cell viability and clone formation assays were used to determine the effect of miR-491 on the proliferation ability of CC cells. The targeting relationship between miR-491 and TPX2 was verified by dual-luciferase reporter assay. Scratch and invasion assays were used to detect the effect of miR-491 on the invasion and migration of CC cells. A nude mouse tumorigenic model was constructed to verify the effects of miR-491 and TPX2 on tumor growth.
      Results  The results of the study showed that the expressions of miR-491 in CC tissues and cells were significantly reduced, while the expressions of TPX2 were significantly increased, and the differences were statistically significant (P<0.05). Overexpression of miR-491 could inhibit the cell proliferation of CC cells. The results of the dual luciferase report showed that miR-491 could significantly reduce the luciferase activity of PmirGLO-TPX2-3′UTR WT compared with the NC group (P<0.05). The test results of cell viability and apoptosis found that miR-491 mimics can significantly inhibit cell proliferation and increase the rate of apoptosis by regulating TPX2. Further scratches and transwell detection revealed that the miR-491 overexpression inhibited cell migration and invasion, while overexpression of TPX2 could promote cell migration and invasion. In addition, this effect was reversed by the overexpression of miR-491. From the results of tumor volume and weight detection, it is found that miR-491 could inhibit tumor growth, while overexpression of TPX2 can promote tumor growth, and its promotion effect was reversed by miR-491. Further detection of hematoxylin and eosin staining(HE) showed that the tumor tissues in the miR-491 group showed partial ring necrosis, while the tumor cell proliferation effect in the TPX2 group was obvious.
      Conclusion  This study confirms that miR-491 can affect the progress of CC by regulating the expression of TPX2, which provides a theoretical basis for the selection of cervical cancer biomarkers and therapeutic targets in the future.

     

/

返回文章
返回